Frontlight ResearchEarly access
CompletedNo phase
MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation
Key facts
- Who runs it
- Dopavision GmbH
- Where
- Germany, Netherlands, Portugal, Spain, and United Kingdom10 sites in 5 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 124 people enrolled
- Started
- 16 Nov 2021
- Ended
- 4 Oct 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- MyopiaX
- Myopia control spectacles
- Record updated
- 28 October 2024
Who can take part
- Age
- 6 years to 12 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Myopic children (-0.75 to -5.0 D SER, least myopic meridian -0.50 D in each eye)
- At least VA 0.2 LogMAR in each eye
- Age: 6 - 12 years old
- Good tolerability of test session with VR system
- Binocular adequacy as tested with VR
- Ability to understand treatment and give valid assent
Who cannot take part
- Concomitant or previous therapies for myopia
- Eye diseases/conditions:
- Systemic illnesses affecting eye health, eye growth, and/or refraction
- Any illnesses affecting dopamine function (e.g., sleep disorder)
- Medication affecting dopamine function, accommodation, pupil size, or having an impact on the ocular surface (such as allergy medications)
- Medical history (or family history) of photosensitive epilepsy
- Anisometropia ≥ 1.5 D
- Astigmatism ≥ 3 D
- Ophthalmological comorbidities
- Optic nerve abnormalities
- Suspicion of syndromic or monogenetic myopia
- Participation in other clinical studies
This trial has no sites in United States.
It has sites in 5 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this trial is to investigate the safety and efficacy of MyopiaX - a digital treatment intended to slow the progression of myopia in children and adolescents.
The 2 groups in the trial
- MyopiaXTreatment being tested
MyopiaX treatment
- Myopia control spectaclesExisting treatment, for comparison
Clinically validated treatment to control myopia
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Record updated
- 28 October 2024